Please provide your email address to receive an email when new articles are posted on . Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a ...

MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass, an innovative medical device company pioneering advancements in the treatment of complex peripheral artery disease (PAD), announces enrollment of the ...

Femoral-popliteal bypass was associated with a significantly higher reintervention rate than stenting in a cohort of individuals with peripheral arterial disease. Perspective from Robert Yeh, MD The ...

LEOMINSTER — Longtime vascular surgeon and founding member of The Vascular Care Group, Dr. Stephen Hoenig recently completed a successful percutaneous femoral-popliteal artery bypass at its Merriam ...

RECONSTRUCTIVE arterial surgery has now progressed to a time when the majority of patients with ischemic disease of the lower extremities, associated with either complete or partial large-vessel ...

Designation Expedites Physician Access to Device for Patients with Extremely Long and Complex SFA Lesions PQ Bypass Inc, a medical device pioneer bringing new advancements to the treatment of advanced ...

In contrast to minimally invasive stenting, a so-called femoral-popliteal bypass requires a large incision to open the leg, and the surgical attachment of a piece of vein or a synthetic tube above and ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--PQ Bypass, a medical technology company pioneering a fully percutaneous approach to femoral-popliteal bypass surgery, today announced the addition of several ...

Initial technical success of the primary intraoperative balloon angioplasty and stenting was 100%. No major procedure-related complications were recorded. The mean operative time was 200 minutes ...

In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader ...